Gilead Sciences, Yipinhong Pharmaceutical and Mass General Brigham Ventures helped the slow-release drug developer secure series C cash bringing its overall funding to almost $250m.
Month: June 2021
Kindbody consults GV in $62m series C
GV participated in a series C round for the fertility and gynaecology services provider at a $612m valuation, doubling its overall funding.
Classplus graduates to $65m series C
The Gree and Bennett Coleman & Co-backed education software provider boosted its series C round to $65m, with Tiger Global Management leading the deal.
Mastercard backs Deserve in $50m series D
Mastercard and Ally Ventures co-led a round which will support the credit card services provider’s expansion, boosting its total funding to over $140m.
Analysis: Manbang Group goes public
A number of corporate backers scored an exit from trucking services marketplace Full Truck Alliance (Manbang Group), as the latter went public in the US. This transaction exemplifies an upward trend in exits for corporate-backed businesses from the transport and mobility space.
Daily Deal Round Up: June 25, 2021
Waste management software provider Recycle Track Systems bagged $35m in a Citi-led series C round while muscular dystrophy drug developer Vita Therapeutics completed a $32m series A.
Garratt goes from Salesforce Ventures to CRV
Matt Garratt, who helped set up Salesforce Ventures, is taking a general partner role at venture firm CRV and is being replaced as managing partner by Alex Kayyal.
Xpeng drives to dual-listed IPO
The EV manufacturer, backed by Alibaba, Duowan, Foxconn, UCar and Xiaomi, has filed to float in Hong Kong, and will potentially raise almost $2bn.
Figma designs $200m series E round
The OATV-backed user interface software provider increased its valuation fivefold to $10bn in a round co-led by Morgan Stanley and Durable Capital Partners.
Corporates assist SmartAsset in $110m series D
Citi, Cuna Mutual Group and New York Life have contributed to a series D round for the financial advice provider at a valuation topping $1bn.
Vercel raises $102m in series C
GV, Latacora and Salesforce Ventures helped the app development technology provider close its latest round, which will support hiring and research and development.
Abbisko aims for Hong Kong IPO
The AstraZeneca, Sinopharm and Eli Lilly-backed oncology drug developer has revealed its intention to go public in a Hong Kong IPO that could reportedly fetch $250m.
Incorta warehouses $120m in series D round
The data warehousing software developer has received cash from investors including GV, Telstra Ventures, M12 and National Grid Ventures to bring its total funding to $195m.
Monte Rosa blows through $222m IPO
GV notched up an exit as cancer therapy developer Monte Rosa Therapeutics priced an upsized initial public offering at the top of its range.